As of 2025-10-17, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (74.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 111.18 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -166.7%.
The range of the Relative Valuation is (63.34) - (75.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 27.5x | 24.1x |
| Forward P/E multiples | 23.0x - 31.1x | 29.7x |
| Fair Price | (63.34) - (75.68) | (74.14) |
| Upside | -157.0% - -168.1% | -166.7% |
| Date | P/E |
| 2025-10-16 | -40.34 |
| 2025-10-15 | -39.68 |
| 2025-10-14 | -38.17 |
| 2025-10-13 | -36.56 |
| 2025-10-10 | -36.58 |
| 2025-10-09 | -36.36 |
| 2025-10-08 | -36.37 |
| 2025-10-07 | -36.22 |
| 2025-10-06 | -35.51 |
| 2025-10-03 | -35.93 |
| 2025-10-02 | -35.28 |
| 2025-10-01 | -36.29 |
| 2025-09-30 | -36.64 |
| 2025-09-29 | -36.51 |
| 2025-09-26 | -35.98 |
| 2025-09-25 | -35.97 |
| 2025-09-24 | -35.16 |
| 2025-09-23 | -35.81 |
| 2025-09-22 | -35.92 |
| 2025-09-19 | -34.85 |
| 2025-09-18 | -35.75 |
| 2025-09-17 | -34.87 |
| 2025-09-16 | -34.66 |
| 2025-09-15 | -34.84 |
| 2025-09-12 | -34.91 |
| 2025-09-11 | -35.53 |
| 2025-09-10 | -36.38 |
| 2025-09-09 | -36.81 |
| 2025-09-08 | -36.20 |
| 2025-09-05 | -37.05 |
| 2025-09-04 | -37.94 |
| 2025-09-03 | -36.90 |
| 2025-09-02 | -37.81 |
| 2025-08-29 | -37.43 |
| 2025-08-28 | -37.82 |
| 2025-08-27 | -37.12 |
| 2025-08-26 | -36.72 |
| 2025-08-25 | -35.99 |
| 2025-08-22 | -37.47 |
| 2025-08-21 | -36.89 |
| 2025-08-20 | -35.81 |
| 2025-08-19 | -35.26 |
| 2025-08-18 | -35.59 |
| 2025-08-15 | -35.42 |
| 2025-08-14 | -35.01 |
| 2025-08-13 | -35.51 |
| 2025-08-12 | -35.00 |
| 2025-08-11 | -34.22 |
| 2025-08-08 | -33.37 |
| 2025-08-07 | -33.55 |